SCHEMBL28570441

SCHEMBL28570441

CC(CCCCOc1ccc2c(c1)OCO2)C(=O)Oc1ccc2c(c1)OCO2

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.52
▸ MAOB P27338 5/20 0.49
▸ MAOA P21397 2/20 0.48
▸ LTB4R Q15722 1/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ TSHR P16473 2/20 0.46
▸ MAPT P10636 4/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ FKBP1A P62942 1/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28555750 0.96 LMNA (0.53) LMNAMAOBMAOARAB9ANPC1
SCHEMBL11807107 0.81 MAOB (0.52) MAOBMAOARAB9ANPC1TSHR
SCHEMBL4758947 0.80 LMNA (0.65) LMNARAB9ANPC1TSHRMAPT
SCHEMBL11796564 0.79 MAOB (0.50) MAOBMAOARAB9ANPC1TSHR
SCHEMBL28564924 0.78 MAPT (0.55) LMNAMAOBMAOARAB9ANPC1
SCHEMBL11803139 0.78 MAOB (0.49) MAOBMAOARAB9ANPC1TSHR
SCHEMBL11801874 0.78 MAOB (0.49) MAOBMAOARAB9ANPC1TSHR
SCHEMBL11805183 0.78 L3MBTL1 (0.52) MAOBMAOARAB9ANPC1TSHR
SCHEMBL594966 0.78 MAOB (0.57) MAOBMAOARAB9ANPC1TSHR
SCHEMBL13251240 0.77 MAOB (0.60) MAOBMAOARAB9ANPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110407801-B 3, 4-methylenedioxy phenoxy fibrate- (3, 4-methylenedioxy) phenyl ester compound and application thereof in reducing blood fat 陕西中医药大学 2020-12-22 — — CN disclosed
Send feedback